XTuit Pharmaceuticals, Inc. is a biopharmaceutical company developing novel microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response.

from http://xtuit.com/

Patents 18show all

  • 11
    A61K - Preparations for medical, dental, or toilet purposes
  • 3
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 3
    C08G - Macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
  • 2
    A61B - Diagnosis
  • 2
    C07K - Peptides
  • 1
    G01N - Investigating or analysing materials by determining their chemical or physical properties

SEC Filings show all


3
D

Contact Information

Waltham, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2014-12-05$10,000,000$4,000,000Equity
2014-01-31$1,508,513$1,508,513Equity

Key Executives

  • Alan Crane
    Executive Officer, Director
  • Rakesh Jain
    Director
  • Robert Langer
    Director